Xconomy | Boston - Business + Technology in the Exponential Economy

Drugs, Asthma, Life Sciences

AstraZeneca Plans Local Job Cuts, Report Says

Ryan McBride 9/11/09

London-based drug giant AstraZeneca (LON:AZN) plans to eliminate 113 jobs at its Westborough, MA, plant next month due to generic drug competition for its asthma drug budesonide (Plumicourt), the Boston Globe reports. Our Boston Tech Layoff Tracker has been updated accordingly. AstraZeneca also has a large R&D operation in Waltham, MA, where the company recently completed a major expansion to its facilities, according to the newspaper.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.